Vaccines Europe - 22 Jan 2016
With the changing demographic structure of the EU population and the rising threats of emerging medical needs such as antimicrobial resistance and healthcare associated infections, there is a fundamental need to define mechanisms capable of prioritising and advising on innovative vaccines needed to protect public health.
The impact of a Joint Action and collaboration at EU level should be to foster innovation for a social purpose at least on three levels:
I. Better prevention and health outcomes from diseases that can be avoided;
II. Sustainable healthcare systems and freeing of resources for medical innovation; and
III. Sustained research and industry investment in the interest of public health needs as to ensure the sustainability of immunisation programmes.
Please find the Vaccines Europe Proposal for an EU Joint Action on Vaccination here.